Isbir Sentetik Dokuma Sanayi AS
IST:ISSEN.E
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
9.46
15.08
|
Price Target |
|
We'll email you a reminder when the closing price reaches TRY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Abbvie Inc
NYSE:ABBV
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Realty Income Corp
NYSE:O
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Isbir Sentetik Dokuma Sanayi AS
Other Liabilities
Isbir Sentetik Dokuma Sanayi AS
Other Liabilities Peer Comparison
Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
I
|
Isbir Sentetik Dokuma Sanayi AS
IST:ISSEN.E
|
Other Liabilities
â‚ş24.9m
|
CAGR 3-Years
60%
|
CAGR 5-Years
52%
|
CAGR 10-Years
N/A
|
S
|
Sonmez Filament Sentetik Iplik ve Elyaf Sanayi AS
IST:SONME.E
|
Other Liabilities
â‚ş474.6k
|
CAGR 3-Years
63%
|
CAGR 5-Years
52%
|
CAGR 10-Years
N/A
|
Aksa Akrilik Kimya Sanayii AS
IST:AKSA.E
|
Other Liabilities
â‚ş122.1m
|
CAGR 3-Years
29%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
Isiklar Enerji ve Yapi Holding AS
IST:IEYHO.E
|
Other Liabilities
â‚ş48.2m
|
CAGR 3-Years
39%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
S
|
Sonmez Pamuklu Sanayii AS
IST:SNPAM.E
|
Other Liabilities
â‚ş10m
|
CAGR 3-Years
54%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
Bossa Ticaret ve Sanayi Isletmeleri TAS
IST:BOSSA.E
|
Other Liabilities
â‚ş286.3m
|
CAGR 3-Years
105%
|
CAGR 5-Years
54%
|
CAGR 10-Years
N/A
|
See Also
What is Isbir Sentetik Dokuma Sanayi AS's Other Liabilities?
Other Liabilities
24.9m
TRY
Based on the financial report for Dec 31, 2023, Isbir Sentetik Dokuma Sanayi AS's Other Liabilities amounts to 24.9m TRY.
What is Isbir Sentetik Dokuma Sanayi AS's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
52%
Over the last year, the Other Liabilities growth was -34%. The average annual Other Liabilities growth rates for Isbir Sentetik Dokuma Sanayi AS have been 60% over the past three years , 52% over the past five years .